Fulcrum Therapeutics, Inc.
2019 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 30 | 0.0% | 2,651 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 31 | 0.0% | 3,334 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 23 | 0.0% | 3,332 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 13 | 0.0% | 4,496 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 21 | 0.0% | 4,496 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 16 | 0.0% | 4,496 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 28 | 0.0% | 4,496 | 6/30/2024 |
| 2023 Q1 | 5/9/2023 | 155 | 0.0% | 54,299 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 366 | 0.0% | 50,324 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 372 | 0.0% | 46,031 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 180 | 0.0% | 36,701 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 819 | 0.0% | 34,642 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 649 | 0.0% | 36,704 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 406 | 0.0% | 14,396 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 320 | 0.0% | 30,559 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 303 | 0.0% | 25,687 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 266 | 0.0% | 22,701 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 168 | 0.0% | 21,171 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 351 | 0.0% | 19,209 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 229 | 0.0% | 19,209 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 115 | 0.0% | 6,897 | 12/31/2019 |